PRLAX | RLAIX | PRLAX / RLAIX | |
Total Expense Ratio | 1.46 | 1.08 | 135% |
Annual Report Gross Expense Ratio | 1.46 | 1.19 | 123% |
Fund Existence | 31 years | 8 years | - |
Gain YTD | 22.243 | 22.381 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 365M | 365M | 100% |
Annual Yield % from dividends | 2.93 | 3.46 | 85% |
Returns for 1 year | -0.45 | -0.13 | 345% |
Returns for 3 years | 12.38 | 13.60 | 91% |
Returns for 5 years | 37.48 | 39.60 | 95% |
Returns for 10 years | 12.92 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LCRIX | 22.09 | 0.06 | +0.27% |
Leuthold Core Investment Institutional | |||
AFGFX | 77.27 | -0.05 | -0.06% |
Virtus Silvant Focused Growth R6 | |||
CLWFX | 75.50 | -0.07 | -0.09% |
Columbia Large Cap Growth Inst2 | |||
MXCAX | 11.35 | -0.09 | -0.79% |
BlackRock Emerging Markets Ex-Chn Inv A | |||
NMMEX | 15.99 | -0.17 | -1.05% |
Northern Active M Emerging Market Equity |